Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HR 44Session 89R

What changed between versions

9 paragraphs changed+33 words added−5 removed

Highlighted text was added in the newer version. Struck-through text was removed.

89R5211 TBO-F

By: Lalani

H.R. No. 44

46 unchanged paragraphs

R E S O L U T I O N

WHEREAS, Hypertrophic Cardiomyopathy Awareness Day is taking

place on February 26, 2025, and this occasion provides a fitting

opportunity to promote better understanding of this health issue;

and

WHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic

cardiovascular disease that involves thickening of the heart muscle

and can potentially lead to debilitating symptoms and serious

complications, including heart failure, atrial fibrillation,

stroke, and in rare cases, sudden cardiac death; and

WHEREAS, HCM is the most common inheritable heart disease; it

can affect anyone, regardless of age, gender, or ethnicity, and it

has a reported prevalence ranging from 1 in 200 individuals to 1 in

500 individuals in the general population; recent reports show that

the number of people in Texas who have HCM range from 58,000 to

nearly 147,000, although approximately 85 percent of cases remain

undiagnosed; and

WHEREAS, HCM shares symptoms with other common

cardiovascular and pulmonary diseases, such as shortness of breath,

chest pain, fatigue, palpitations, and fainting, and those

similarities make it difficult to accurately diagnose HCM; in

addition, the all-cause mortality risk is three to four times

higher in patients with HCM than that of the general population; it

is important that patients know their medical history and stay

informed about the signs and symptoms of HCM; and

WHEREAS, In order to help identify a risk of both genetic and

congenital cardiac disorders, health care providers conduct

thorough screenings with cardiac health questions; they may also

conduct several tests, including an echocardiogram, a cardiac MRI,

or genetic testing to confirm a family history of HCM, and they must

examine the heart to diagnose HCM; and

WHEREAS, Following a diagnosis of HCM, patients are advised

to work with their health care providers to learn more about the

disease and different management options, such as prescription

medicines and surgical treatments; and

WHEREAS, Hypertrophic cardiomyopathy is a serious and

life-threatening disease, and the observance of Hypertrophic

Cardiomyopathy Awareness Day unites people around the world in

their commitment to improving the quality of life for patients;

now, therefore, be it

RESOLVED, That the House of Representatives of the 89th Texas

Legislature hereby recognize February 26, 2025, as Hypertrophic

Cardiomyopathy Awareness Day and urge all Texans to learn more

about the disease; and, be it further

RESOLVED, That an official copy of this resolution be

prepared for the Hypertrophic Cardiomyopathy Association as an

expression of high regard by the Texas House of Representatives.

Lalani

______________________________

Speaker of the House

I certify that H.R. No. 44 was adopted by the House on

February 26, 2025, by a non-record vote.

______________________________

Chief Clerk of the House

Back to the full text